It has been reported that the synergistic effects of GABA and GLP−1 may contribute to the prevention of diabetes by preserving pancreatic beta cell mass and reversing apoptosis, compared with the use of a standalone drug [115]. Here, GLP1R is linked to diabetes mellitus.